Technology
New On Robinhood
Health

NextCure

$26.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.81 (3.15%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell NextCure and other stocks, options, ETFs, and crypto commission-free!

About NXTC

NextCure, Inc. Common Stock, also called NextCure, is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Read More Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.

Employees
44
Headquarters
Beltsville, Maryland
Founded
2015
Market Cap
603.31M
Price-Earnings Ratio
Dividend Yield
Average Volume
78.62K
High Today
$27.50
Low Today
$25.89
Open Price
$25.89
Volume
41.19K
52 Week High
$28.00
52 Week Low
$13.86

Collections

Technology
New On Robinhood
Health
Biotechnology
Medical
Biopharmaceutical
Cancer Prevention
Pharmaceutical

NXTC Earnings

-$5.35
-$4.76
-$4.16
-$3.57
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 12, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.